Print Page | Contact Us | Sign In
Autism Research Series: Discovery to Solutions
Tell a Friend About This EventTell a Friend
Autism Research Series: Discovery to Solutions

A community science event hosted by Autism Speaks Chief Science Officer Thomas Frazier, Ph.D, exploring the latest advances in autism research to support individuals with autism and their families.

9/9/2017
When: Saturday, September 9, 2017
11:00am - 1:00pm
Where: GE Healthcare Research Park
9900 West Innovation Dr
Wauwatosa, Wisconsin  53226
United States
Contact:

« Go to Upcoming Event List  

Who should attend: Open to all, including people with autism and their families,  researchers, educators, clinicians, policy makers and members of the local community.

 

Light refreshments will be provided.

There is no fee to attend, but registration is required. 

RSVP now at  ACT.AutismSpeaks.org/AutismResearchSeriesWisconsin


Dr. Frazier is a licensed clinical psychologist who received his B.S. in psychology from John Carroll University in 1997 and his Ph.D. from Case Western Reserve University in 2004. After one year as a visiting assistant professor at John Carroll University, he joined Cleveland Clinic and until recently was the director of the Cleveland Clinic Center for Autism and an Assistant Professor of Pediatrics in the Cleveland Clinic Lerner College of Medicine. On April 1, Dr. Frazier joined Autism Speaks as Chief Science Officer.

Dr. Frazier’s clinical interests include diagnostic evaluation as well the use of intensive behavioral intervention to improve functional outcomes on individuals with autism. In 2008, he re-trained in the leadership of translational science teams. Since that time, his research has focused on two areas: 1) improving early identification through the development of objective markers of autism using remote eye gaze tracking, and 2) translational studies of a genetic sub-group of autism associated with PTEN mutations. Dr. Frazier is also the father of a 13-year old son with autism. At Autism Speaks, Dr. Frazier oversees the science portfolio and hopes to continue the excellent tradition of funding the most innovative and impactful autism research that can ultimately enhance the lives of people with autism.